Annual Results
2012
Audited results for the year ended 31 March 2012
Highlights
-
Profit for the year up 39% to a record high R629 million
-
Operating margin up from 7,3% to 8,1%
-
EPS up 24% to 949,6 cents per share on 14% more average shares in issue
- Total dividend for the year 280 cents
- Debt:equity ratio at 19% after capex on new nitric acid complex
- New nitric acid complex commissioned on time and within budge
2011
Audited results for the year ended 31 March 2011
Highlights:
-
Profit after tax up 678% to R451 million
-
Operating profit margin improves from 3.2% to 7.3%
-
Lower finance costs
-
Successful completion of R1billion Rights Offer
-
Debt: equity ratio improves to 10%
2010
Reviewed provisional results for the year ended 31 March 2010
Highlights
-
Revenue down 21% to R8,8 billion
-
Profit for the year R58 million (2009: Profit R491 million)
-
Basic earnings per share 112,0 cents (2009: 1 097,1 cents per share)
-
Strong cash generation of R1 billion (2009: R143 million utilised)
-
Planned R1,4 billion investment in second nitric acid complex through equity capital raising and debt
2009
Reviewed provisional results for the year ended 31 March 2009
Highlights
- Revenue increased by 51% to R11 billion
- Net profit for the year increased by 57% to R491 million
- Basic earnings per share increased by 54% to 1107,4 cents
- Headline earnings per share increased by 54% to 1114,2 cents
- Capitalisation award of 150 cents per share brings the total dividend to 250 cents for the year, representing an increase of 25% from the prior year
2008
Reviewed provisional results for the year ended 31 March 2008
Highlights
- Revenue increased by 33% to R7,3 billion
- Net profit for the year increased by 27% to R313 million
- Basic earnings per share increased by 28% to 718,2 cents
- Headline earnings per share increased by 30% to 724,5 cents
- Final dividend distribution to shareholders of 117 cents (200 cents for the full year, an increase of 25%)
|
